Public Profile

Evotec

Evotec SE, a leading global biotechnology company headquartered in Germany, is renowned for its innovative drug discovery and development solutions. Founded in 1993, Evotec has established a strong presence in Europe, North America, and Asia, focusing on areas such as central nervous system disorders, metabolic diseases, and oncology. The company offers a unique platform that integrates cutting-edge technologies and extensive expertise, enabling efficient and effective drug development processes. Notable achievements include strategic partnerships with major pharmaceutical firms, positioning Evotec as a key player in the biopharmaceutical industry. With a commitment to advancing healthcare, Evotec continues to drive progress in the development of novel therapeutics, making significant contributions to the global fight against disease.

DitchCarbon Score

How does Evotec's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

85

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

25

Industry Benchmark

Evotec's score of 85 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

100%

Let us know if this data was useful to you

Evotec's reported carbon emissions

In 2024, Evotec reported total carbon emissions of approximately 300,670,000 kg CO2e, with Scope 1 emissions at about 15,937,000 kg CO2e, Scope 2 emissions (market-based) at approximately 11,672,000 kg CO2e, and a significant contribution from Scope 3 emissions, which totalled around 273,060,000 kg CO2e. This represents a notable increase from 2023, where total emissions were about 206,423,000 kg CO2e. Evotec has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 50.4% by 2032 from a 2021 base year. Additionally, the company plans to achieve net-zero emissions across all scopes by 2045. For Scope 3 emissions, Evotec targets a reduction of 72% per million EUR value added by 2032, alongside a commitment that 80% of its suppliers will have science-based targets by 2027. These targets align with the 1.5°C climate scenario, demonstrating Evotec's commitment to sustainability and responsible environmental stewardship within the pharmaceutical and biotechnology sector. The company is also focused on increasing its sourcing of renewable electricity from 25% in 2021 to 100% by 2026, further supporting its climate action goals.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201920202021202220232024
Scope 1
28,000
00,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
-
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Evotec's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Evotec is in DE, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Evotec is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Curia

US
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Almirall

ES
Pharmaceutical Preparation Manufacturing
Updated about 20 hours ago

Twist Bioscience Corporation

US
Health and social work services (85)
Updated 20 days ago

Pharmaceutical Product Development, LLC

US
Research and development services (73)
Updated 4 months ago
DitchCarbon Score

Alk

DK
Medical, precision and optical instruments, watches and clocks (33)
Updated 23 days ago

Certara

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 7 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers